GTCEX
Price
$28.55
Change
+$0.22 (+0.78%)
Updated
Jul 3 closing price
Net Assets
155.77M
RWEBX
Price
$64.15
Change
+$0.53 (+0.83%)
Updated
Jul 3 closing price
Net Assets
202.05B
Interact to see
Advertisement

GTCEX vs RWEBX

Header iconGTCEX vs RWEBX Comparison
Open Charts GTCEX vs RWEBXBanner chart's image
Glenmede Strategic Equity
Price$28.55
Change+$0.22 (+0.78%)
VolumeN/A
Net Assets155.77M
American Funds Washington Mutual R2E
Price$64.15
Change+$0.53 (+0.83%)
VolumeN/A
Net Assets202.05B
GTCEX vs RWEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GTCEX vs. RWEBX commentary
Jul 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTCEX is a StrongBuy and RWEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 202B vs. GTCEX (156M). RWEBX pays higher dividends than GTCEX: RWEBX (0.80) vs GTCEX (0.36). GTCEX was incepted earlier than RWEBX: GTCEX (36 years) vs RWEBX (11 years). RWEBX (1.06) is less costly to investors than GTCEX (0.87). RWEBX is a more actively managed with annual turnover of: 31.00 vs. GTCEX (4.00). GTCEX has a lower initial minimum investment than RWEBX: GTCEX (0) vs RWEBX (250). RWEBX annual gain was more profitable for investors over the last year : 7.02 vs. GTCEX (0.08). RWEBX return over 5 years is better than : 52.48 vs. GTCEX (14.63).
GTCEXRWEBXGTCEX / RWEBX
Total Expense Ratio0.871.0682%
Annual Report Gross Expense Ratio0.871.0682%
Fund Existence36 years11 years-
Gain YTD4.9905.31994%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets156M202B0%
Annual Yield % from dividends0.360.8045%
Returns for 1 year0.087.021%
Returns for 3 years7.9629.5927%
Returns for 5 years14.6352.4828%
Returns for 10 years40.3565.5662%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLK1.780.07
+4.09%
Outlook Therapeutics
GLRE14.320.17
+1.20%
Greenlight Capital Re Ltd
RGEN127.470.51
+0.40%
Repligen Corp
TGI25.820.09
+0.35%
Triumph Group
NUWE0.20-0.02
-10.57%
Nuwellis Inc